Pharmaceutical Project Solutions, Inc.   Report issue

For profit Phase 4
Founded: Riverview FL United States (2008)

Organization Overview

First Clinical Trial
2014
NCT02667054
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Pharmaceutical Project Solutions, Inc.

Active Ingredients

Drugs in Phase 4 Trials (1)

cocaine (Erythroxyline) (5 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Drug-Related Side Effects and Adverse Reactions (Phase 3)

Renal Insufficiency (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 1